Volpara Health Technologies Margine lordo
Cos'è Margine lordo di Volpara Health Technologies?
Margine lordo di Volpara Health Technologies Limited è 92.46%
Qual è la definizione di Margine lordo?
Il margine lordo è la differenza tra entrate e costo del venduto, diviso per ricavo ed espresso in percentuale.
Gross margin is a type of profit margin, specifically a form of profit divided by net revenue. It is generally calculated as the selling price of an item, minus the cost of goods sold (production or acquisition costs, not including indirect fixed costs like rent, or administrative costs). The purpose of margins is to give a description of the gross profit.
Margine lordo di aziende nel Health Care settore su ASX rispetto a Volpara Health Technologies
Cosa fa Volpara Health Technologies?
Volpara Health Technologies Limited provides breast imaging analytics and analysis products for the early detection of breast cancer in the medical device and practice management software industry worldwide. The company offers Volpara Analytics software, a cloud-based breast imaging analytics platform that delivers performance monitoring solutions; Volpara Live, which provides radiographers instant patient-based image quality feedback; Volpara Lung, a patient management software; and Volpara Patient Hub, a customizable mammography reporting and patient communications software. It also offers Volpara Risk, an integration with Patient Hub that uses Tyrer-Cuzick v8 Risk Evaluation Tool to calculate patients' risk of developing breast cancer; Volpara Scorecard, which displays patient breast density and risk insights essential for improved clinical decision-making and early detection; and Volpara Science, an AI-based software that powers Volpara software products. In addition, the company provides TruDensity, a Volpara clinical function; TruPGMI, a Volpara clinical function, which uses artificial intelligence to automatically and objectively assess the positioning of the patient and resulting image quality; TruPressure, a Volpara clinical function, which determines whether the compression pressure applied by the radiographer is in the sweet spot that yields quality images, minimal radiation exposure, and the least discomfort; and TruRadDose, a Volpara clinical function which analyses the radiation dose delivered to patients based on their breast density. Volpara Health Technologies Limited has a strategic relationship with RevealDx to enhance lung screening capabilities. The company was formerly known as Matakina Technology Ltd. and changed its name to Volpara Health Technologies Limited in October 2015. Volpara Health Technologies Limited was incorporated in 2009 and is headquartered in Wellington, New Zealand.
Aziende con margine lordo simili a Volpara Health Technologies
- Future Market Networks ha Margine lordo di 92.38%
- Assura Plc ha Margine lordo di 92.40%
- Corporacion Financiera Alba, S.A ha Margine lordo di 92.43%
- Neoen S.A ha Margine lordo di 92.43%
- China International Capital ha Margine lordo di 92.44%
- Schroder British Opportunities Ltd ha Margine lordo di 92.45%
- Volpara Health Technologies ha Margine lordo di 92.46%
- Elanor Commercial Property Fund ha Margine lordo di 92.48%
- Lineage Cell Therapeutics Inc ha Margine lordo di 92.50%
- Dorchester Minerals LP ha Margine lordo di 92.55%
- Vastned Retail NV ha Margine lordo di 92.57%
- OneMain Inc ha Margine lordo di 92.61%
- MAS Services ha Margine lordo di 92.62%